Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.

I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for ...

Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...

I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and ...

A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...

Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, ...

A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.

Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and ...

The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are ...

It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect ...

August is World Cancer Support month, and a time to honor the quiet strength of caregivers and the communities that lift them ...